Lawrence Blatt, Ph.D.
Chief Scientific Officer

Dr. Blatt has been with InterMune since May 2002. From January 1998 to May 2002, Dr. Blatt was Vice President of Research at Ribozyme Pharmaceuticals, a biotechnology company. From August 1996 to January 1998, Dr. Blatt served as Vice President, Product Development at National Genetics Institute, a licensed clinical laboratory and from May 1984 to August 1996, Dr. Blatt was employed at Amgen, Inc., a biotechnology company, most recently as Product Development Team Leader, Interferons. Dr. Blatt holds a doctorate in Public Health Administration from the University of La Verne.